Latham & Watkins Advises the Underwriters in the offering while Cooley LLP represented Lyell Immunopharma. Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company...
Lyell Immunopharma’s $425 Million Initial Pubic Offering
Groww’s $83 Million Series D Financing Round
Cooley LLP advised Groww on the deal, and AZB & Partners advised investor Tiger Global Management Bangalore-based Groww, an online investment platform, announced its $83 million Series...
Lattice’s $60 Million Series E Financing Round
Cooley LLP advised Lattice on the deal. Lattice, a people management platform for businesses with people-first cultures, announced its $60 million Series E financing round, which brings...